Eric Duncavage, MD
About Eric Duncavage, MD
Eric Duncavage, MD, serves as the Medical Director at Cofactor Genomics and Geneoscopy, with extensive experience in pathology and immunology. He holds a medical degree from the University of Tennessee and has held various academic and clinical positions, including Professor of Pathology and Immunology at Washington University in St. Louis since 2011.
Work at Cofactor Genomics
Eric Duncavage serves as the Medical Director at Cofactor Genomics, a position he has held since 2015. In this role, he oversees clinical operations and contributes to the development of genomic assays. His expertise in pathology and genomics supports the company's mission to advance precision medicine through innovative genomic solutions. Cofactor Genomics is located in St. Louis, MO, where Duncavage has been instrumental in integrating clinical insights with genomic data.
Education and Expertise
Eric Duncavage's educational background includes a Bachelor of Arts in Physics and Chemistry from Vanderbilt University, completed in 1998. He earned his M.D. from the University of Tennessee-Health Science Center College of Medicine in 2004. Duncavage completed his residency in Anatomic and Clinical Pathology at Washington University School of Medicine in St. Louis from 2004 to 2008. He further specialized in Molecular Genetic Pathology and Hematopathology, completing fellowships at Washington University and the University of Utah School of Medicine, respectively.
Background
Before joining Cofactor Genomics, Eric Duncavage held various positions in academia and research. He worked as a Pre-doctoral fellow at Saint Jude Children's Research Hospital from 2001 to 2002. He served as an Instructor at the University of Utah from 2010 to 2011. Since 2011, he has been a Professor of Pathology and Immunology at Washington University in St. Louis, where he co-directs clinical assay development. His background combines clinical practice with a strong foundation in research.
Achievements
Eric Duncavage is board certified as a Clinical Diagnostic Pathologist and is a member of the Clinical Laboratory Standards Institute (CLSI). His work in clinical assay development at Washington University has contributed to advancements in pathology and genomics. In addition to his role at Cofactor Genomics, he has been involved in various initiatives aimed at improving diagnostic accuracy and patient outcomes in the field of pathology.